The overall purpose of this study is to characterise the clinical safety and performance of the Creo Medical MicroBlate™ Flex AB1 instrument in patients with pathologically confirmed malignancy eligible for surgical resection of their nodule, receiving bronchoscopic ablation prior to surgery.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-11-13; most recent amendment 2026-06-23.
Status change: Not Yet Recruiting → Recruiting2025-04-10